Literature DB >> 21499708

Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.

S J Tozer1, S B Lambert, T P Sloots, M D Nissen.   

Abstract

Q fever is a vaccine preventable disease; however, despite this, high notification numbers are still recorded annually in Australia. We investigated the seroprevalence of Coxiella burnetii, the Q fever agent, in a Queensland sample population. Notification data (N = 6425) from 1984-2008 were collated, identifying high risk areas of Q fever exposure. Of these 177 were recorded in children. Serum samples were collected from Queensland and screened using both an immunoflourescence assay at 1:10 dilution and a commercially available ELISA kit. Results were collated based on age, geographical location and sex. From 1988 Queensland samples screened, 103 were identified as Q fever IgG-positive, giving a seroprevalence of 5.2% (95% CI 4.3-6.2%). Seroprevalence in the rural/remote population was 5.3% (95% CI 4.6-6.6%), and the metropolitan Brisbane population, which is considered not at risk, was 5.0% (95% CI 3.7-6.7%). Sixty-three seropositive males and 40 females were identified, along with an increase in seropositivity with increasing age. The seropositivity of children was 1.3% (95% CI 0.7-2.3%) from 844 samples. We have shown that both metropolitan and paediatric populations which are considered low risk of Coxiella exposure have surprisingly high seropositivity. These emerging groups require further investigation and consideration for the introduction of preventive measures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499708     DOI: 10.1007/s10096-011-1225-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  43 in total

1.  Q fever in children: an emerging public health issue in Queensland.

Authors:  Jennifer H Barralet; Neil R Parker
Journal:  Med J Aust       Date:  2004-06-07       Impact factor: 7.738

Review 2.  Natural history and pathophysiology of Q fever.

Authors:  D Raoult; Tj Marrie; Jl Mege
Journal:  Lancet Infect Dis       Date:  2005-04       Impact factor: 25.071

Review 3.  Q fever.

Authors:  Neil R Parker; Jennifer H Barralet; Alan Morton Bell
Journal:  Lancet       Date:  2006-02-25       Impact factor: 79.321

4.  Australia's national Q fever vaccination program.

Authors:  Heather F Gidding; Cate Wallace; Glenda L Lawrence; Peter B McIntyre
Journal:  Vaccine       Date:  2009-02-12       Impact factor: 3.641

5.  An outbreak of Q fever probably due to contact with a parturient cat.

Authors:  T J Marrie; A MacDonald; H Durant; L Yates; L McCormick
Journal:  Chest       Date:  1988-01       Impact factor: 9.410

6.  Poker players' pneumonia. An urban outbreak of Q fever following exposure to a parturient cat.

Authors:  J M Langley; T J Marrie; A Covert; D M Waag; J C Williams
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

7.  Vaccine prophylaxis of abattoir-associated Q fever.

Authors:  B P Marmion; R A Ormsbee; M Kyrkou; J Wright; D Worswick; S Cameron; A Esterman; B Feery; W Collins
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

8.  Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990.

Authors:  J R Ackland; D A Worswick; B P Marmion
Journal:  Med J Aust       Date:  1994-06-06       Impact factor: 7.738

9.  Q fever in a Queensland meatworks.

Authors:  P McKelvie
Journal:  Med J Aust       Date:  1980-06-14       Impact factor: 7.738

10.  The geographical distribution of Q fever.

Authors:  M M KAPLAN; P BERTAGNA
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

View more
  13 in total

1.  Seroepidemiologic survey for Coxiella burnetii among US military personnel deployed to Southwest and Central Asia in 2005.

Authors:  Joseph Royal; Mark S Riddle; Emad Mohareb; Marshall R Monteville; Chad K Porter; Dennis J Faix
Journal:  Am J Trop Med Hyg       Date:  2013-09-16       Impact factor: 2.345

2.  Trends and risk factors for human Q fever in Australia, 1991-2014.

Authors:  T S Sloan-Gardner; P D Massey; P Hutchinson; K Knope; E Fearnley
Journal:  Epidemiol Infect       Date:  2016-12-08       Impact factor: 4.434

3.  Risk factors of Coxiella burnetii (Q fever) seropositivity in veterinary medicine students.

Authors:  Myrna M T de Rooij; Barbara Schimmer; Bart Versteeg; Peter Schneeberger; Boyd R Berends; Dick Heederik; Wim van der Hoek; Inge M Wouters
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

4.  Vaccination against Q fever for biodefense and public health indications.

Authors:  Sara Ruiz; Daniel N Wolfe
Journal:  Front Microbiol       Date:  2014-12-16       Impact factor: 5.640

5.  Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.

Authors:  Emily Sellens; Jacqueline M Norris; Navneet K Dhand; Jane Heller; Lynne Hayes; Heather F Gidding; Harold Willaby; Nicholas Wood; Katrina L Bosward
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

Review 6.  Seroprevalence of Q fever among human and animal in Iran; A systematic review and meta-analysis.

Authors:  Ashraf Mohabbati Mobarez; Fahimeh Bagheri Amiri; Saber Esmaeili
Journal:  PLoS Negl Trop Dis       Date:  2017-04-10

7.  Q fever seroprevalence in Australia suggests one in twenty people have been exposed.

Authors:  H F Gidding; C Q Peng; S Graves; P D Massey; C Nguyen; J Stenos; H E Quinn; P B McIntyre; D N Durrheim; N Wood
Journal:  Epidemiol Infect       Date:  2020-02-05       Impact factor: 2.451

8.  Estimation of acute and chronic Q fever incidence in children during a three-year outbreak in the Netherlands and a comparison with international literature.

Authors:  Edwin N E Slok; Frederika Dijkstra; Esther de Vries; Ariene Rietveld; Albert Wong; Daan W Notermans; Jim E van Steenbergen
Journal:  BMC Res Notes       Date:  2015-09-18

9.  Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin.

Authors:  Els van der Meijden; Seweryn Bialasiewicz; Rebecca J Rockett; Sarah J Tozer; Theo P Sloots; Mariet C W Feltkamp
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

10.  Seroprevalence and risk factors for <i>Coxiella burnetii</i>, the causative agent of Q fever in the dromedary camel (<i>Camelus dromedarius</i>) population in Algeria.

Authors:  Mohammed H Benaissa; Samir Ansel; Abdallah Mohamed-Cherif; Karima Benfodil; Djamel Khelef; Curtis R Youngs; Rachid Kaidi; Khatima Ait-Oudhia
Journal:  Onderstepoort J Vet Res       Date:  2017-08-31       Impact factor: 1.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.